WallStreetZenWallStreetZen

How to Buy Innate Pharma Sa Stock

Innate Pharma Sa

Innate Pharma S. A. , a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally.

Innate Pharma Sa stock last closed at $2.46, up 2.5% from the previous day, and has decreased 13.99% in one year. It has overperformed other stocks in the Biotechnology industry by 0.08 percentage points. Innate Pharma Sa stock is currently +35.91% from its 52-week low of $1.81, and -31.09% from its 52-week high of $3.57.

There are currently 80.45M shares of IPHA outstanding. The market value of IPHA is $197.92M. In the last 24 hours, 6799 IPHA shares were traded.

How to Buy Innate Pharma Sa Stock

Not sure how to invest in Innate Pharma Sa stock? Here's how.
  1. Figure out where to buy Innate Pharma Sa stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Innate Pharma Sa stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your brokerage account: Select your payment method and add your info.
  4. Analyze Innate Pharma Sa stock: The Innate Pharma Sa ticker symbol is IPHA. Is Innate Pharma Sa stock a good investment? Should you buy shares of IPHA? How do IPHA's underlying business fundamentals look? Do top analysts think Innate Pharma Sa is a good buy? Why has IPHA's stock price moved recently? (Hint: Our stock market research tools can help you figure out if IPHA is a good stock to buy).
  5. Make your IPHA trade: Decide if you will purchase IPHA shares at the current market price or use a limit order to buy IPHA stock at a given price.
  6. Get the latest news on your IPHA position: Create a watchlist to keep track of your investment in Innate Pharma Sa shares.

Step 1: Figure out where to buy Innate Pharma Sa stock

You need a brokerage account to access the NASDAQ market and buy IPHA stock.

A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our research, eToro is the best stock brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to global markets: From Tech to Industrials, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've chosen your brokerage, it's time to fill out some personal information so you can buy IPHA stock today.

How to Set Up a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal details to start your new brokerage account.
  1. Send your application by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you have filled out your info on the best stock market app for beginners, your next step is to transfer the money for your investment:

Check out the walkthrough below if you need help depositing funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Innate Pharma Sa stock

After you have chosen the best place to buy Innate Pharma Sa stock, it's critical to evaluate their stock prior to investing, so you truly wrap your head around the risk and opportunity.

Innate Pharma Sa shares quick numbers

IPHA Price
$2.46
1w %
0.82%
1y %
-13.99%
5y %
N/A
P/E
-25.1x
P/B
3.51x
P/S
2.95x
PEG
N/A
Revenue
$67.00M
Earnings
-$8.23M
Fore. Rev. Growth
6.32%
Fore. Earn. Growth
N/A
Market Cap
$197.92M
Next Earnings
May 14, 2024
Next Dividend
N/A

Fundamentals of Innate Pharma Sa

WallStreetZen was created to help part-time investors perform better fundamental analysis in less time.

You can see all of the due diligence checks on IPHA's stock page.

Is IPHA stock properly valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge IPHA's true value.

Using relative valuations ratios:

  • IPHA could be undervalued based on its P/B ratio of 3.51x, relative to Biotechnology industry P/B ratio of 5.85x

You can do additional valuation research on IPHA's stock here.

IPHA Financials at a glance

Positive Financial Indicators:

  • There are more short-term assets than long-term liabilities on the IPHA balance sheet.
  • IPHA has cash burn of 35607608. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the IPHA balance sheet.
  • IPHA has $100.50M in cash and short term investments. This is enough to cover its annual cash burn of $35.61M.
  • IPHA profit margin has gone up from -100.7% to -12.3% in the past year.

Negative Financial Indicators:

  • Total IPHA debt is higher than 5 years ago, relative to shareholder equity.
  • IPHA has a relatively high debt to equity ratio of 2.55.

Do analysts think it's a good time to buy Innate Pharma Sa stock

Out of 1 sell side analysts who give ratings on IPHA, the consensus analyst rating on Innate Pharma Sa is a Buy

It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are forecasting on the Innate Pharma Sa stock forecast page.

IPHA Momentum

SMA10
2.43
SMA20
2.49
SMA50
2.53
SMA100
2.58
SMA200
2.65
MACD
-0.03
MACD Signal
-0.03
MACD Histogram
0
RSI
48.92
Stochastic %K
33.33
Stochastic %D
23.27
StochRSI %K
51.08
StochRSI %D
40.72

Is IPHA Growing Revenue?

Last year, IPHA revenue was $67.00M. In the last five year, IPHA's revenue has grown by -8.7% per year. This was slower than the Biotechnology industry average of 28.56%.

You can analyze IPHA's earnings and revenue performance here.

Who is buying/selling IPHA?

In the last year, insiders at IPHA have not bought or sold any shares.

Dig into more about who owns IPHA shares here.

Can I rely on IPHA as an income stream?

No, Innate Pharma Sa doesn't provide an income stream by paying out dividends.

What others are saying about IPHA

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Make your IPHA trade

You have two primary options:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are usually fine for most investors.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at a particular dollar amount limit, use a limit order.

Hit the Open Trade button and eToro will execute the order.

If you need additional assistance investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get the latest news on your IPHA position

Now that you own some IPHA shares, you'll want to stay up-to-date on your stock purchase.

Make a watchlist to get alerted to the latest events about your IPHA stock.

IPHA Feed

How to Buy Stock in Innate Pharma Sa

To reiterate, here are the 6 steps for buying Innate Pharma Sa stock:

  1. Figure out where to buy Innate Pharma Sa stock
  2. Sign up for your brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Innate Pharma Sa stock
  5. Make your IPHA trade
  6. Get the latest news on your IPHA position

If you need a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to monitor your new investment in Innate Pharma Sa, create a watchlist on WallStreetZen today.

NASDAQ: IPHA
$2.46+0.06 (+2.5%)
Updated Apr 26, 2024
Open eToro Account
NASDAQ: IPHA
$2.46+0.06 (+2.5%)
Updated Apr 26, 2024
Open eToro Account

FAQ

How much does it cost to buy one Innate Pharma Sa share?

As of Apr 26, 2024, it costs $2.46 to buy one share of Innate Pharma Sa stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.407 shares of IPHA.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Innate Pharma Sa stock?

According to 1 Wall Street analysts who monitor Innate Pharma Sa, their consensus recommendation is to buy Innate Pharma Sa stock.

What is the best way to buy Innate Pharma Sa stock?

One way to place an order for Innate Pharma Sa stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.